Clearbridge Investments LLC Increases Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Clearbridge Investments LLC boosted its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 20.5% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 571,664 shares of the exchange traded fund’s stock after acquiring an additional 97,401 shares during the period. Clearbridge Investments LLC owned about 0.75% of SPDR S&P Biotech ETF worth $51,484,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of XBI. FMR LLC lifted its holdings in shares of SPDR S&P Biotech ETF by 13.6% during the 3rd quarter. FMR LLC now owns 6,940 shares of the exchange traded fund’s stock worth $686,000 after acquiring an additional 830 shares during the period. Ameritas Advisory Services LLC raised its stake in SPDR S&P Biotech ETF by 11.9% during the fourth quarter. Ameritas Advisory Services LLC now owns 10,684 shares of the exchange traded fund’s stock worth $962,000 after purchasing an additional 1,137 shares during the period. Van ECK Associates Corp acquired a new position in shares of SPDR S&P Biotech ETF in the 4th quarter valued at $1,497,000. Hollow Brook Wealth Management LLC grew its stake in shares of SPDR S&P Biotech ETF by 4.9% during the 3rd quarter. Hollow Brook Wealth Management LLC now owns 21,669 shares of the exchange traded fund’s stock valued at $2,141,000 after buying an additional 1,003 shares during the period. Finally, Parallel Advisors LLC increased its holdings in shares of SPDR S&P Biotech ETF by 3.8% during the 4th quarter. Parallel Advisors LLC now owns 42,574 shares of the exchange traded fund’s stock worth $3,834,000 after buying an additional 1,568 shares during the last quarter.

SPDR S&P Biotech ETF Trading Down 3.9 %

Shares of XBI opened at $81.10 on Tuesday. SPDR S&P Biotech ETF has a twelve month low of $79.33 and a twelve month high of $105.47. The firm has a market capitalization of $5.26 billion, a P/E ratio of 11.47 and a beta of 0.99. The stock’s fifty day simple moving average is $89.27 and its 200 day simple moving average is $93.78.

SPDR S&P Biotech ETF Cuts Dividend

The company also recently disclosed a dividend, which was paid on Wednesday, March 26th. Stockholders of record on Monday, March 24th were paid a $0.0053 dividend. The ex-dividend date of this dividend was Monday, March 24th.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.